BPC-157 vs CJC-1295 (no DAC)
Both BPC-157 and CJC-1295 (no DAC) are used for recovery. Here's how their evidence, dosing, and regulatory status actually compare.
BPC-157
Evidence B+Body Protection Compound-157
A 15-amino-acid peptide derived from gastric juice. The most popular recovery peptide with 100+ preclinical studies showing accelerated healing of tendons, ligaments, muscle, gut lining, and nerves.
View full BPC-157 profile →CJC-1295 (no DAC)
Evidence BModified Growth Hormone Releasing Factor 1-29
A growth hormone releasing hormone (GHRH) analog most commonly stacked with Ipamorelin to stimulate natural GH pulsatile release without disrupting the hypothalamic axis.
View full CJC-1295 (no DAC) profile →Side-by-Side
| Attribute | BPC-157 | CJC-1295 (no DAC) |
|---|---|---|
| Evidence Grade | B+ | B |
| FDA Status | Not FDA-approved — Category 2 (reclassification to Cat 1 expected 2026) | Not FDA-approved — Category 1 (compounding allowed) |
| Typical Dose | 250–500 mcg twice daily (subcutaneous) | 100–300 mcg before bed (subcutaneous) |
| Clinics Indexed | 308 | 156 |
| Categories | recovery, gut-health | growth-hormone, anti-aging, recovery |
Key reported benefits — BPC-157
- ✓Tendon & ligament repair
- ✓Gut healing
- ✓Muscle recovery
- ✓Neuroprotection
Key reported benefits — CJC-1295 (no DAC)
- ✓Growth hormone release
- ✓Fat loss
- ✓Improved sleep
- ✓Muscle recovery
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.